Wooster
Andrew Kenneth Michael Wooster, Waterloo CA
Patent application number | Description | Published |
---|---|---|
20120218452 | Simulated Incident Light Meter on a Mobile Device for Photography/Cinematography - A mobile telecommunications device is provided. The mobile telecommunications device comprises a light sensor and a calculation component. Adjustments to at least one of the brightness of a display screen on the mobile telecommunications device and the backlighting of a keypad on the mobile telecommunications device are based on light sensed by the light sensor. The calculation component is configured to receive a light level measurement from the light sensor and generate a photography-related output based on the light level measurement. | 08-30-2012 |
Jeffrey J. Wooster, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20080255296 | Polyolefin Based Peelable Seals - The invention relates to a polyolefin-based heat sealable and peelable seal. The peelable seals comprise from 5 to 98 percent by weight of a propylene based plastomer or elastomer and from 2 to 95 percent by weight of a second polymer selected from the group consisting of polyethylene, polybutylene, and styrenic polymer and mixtures thereof. The invention also relates to tamper evident peelable seals. The invention also relates to methods of making and using the heat sealable, peelable seal. | 10-16-2008 |
20100144533 | DELIVERY OF ETHYLENE BLOCKING AND/OR PROMOTING AGENTS - A composition including an ethylene blocking agent complex formed from the product of an ethylene blocking agent and a host, and at least one water-soluble polymer, wherein the ethylene blocking agent complex and the at least one water-soluble polymer are intermingled is disclosed. | 06-10-2010 |
20140094369 | DELIVERY OF ETHYLENE BLOCKING AND/OR PROMOTING AGENTS - A composition including an ethylene blocking agent complex formed from the product of an ethylene blocking agent and a host, and at least one water-soluble polymer, wherein the ethylene blocking agent complex and the at least one water-soluble polymer are intermingled is disclosed. | 04-03-2014 |
Maurice William Wooster, Upper Hutt NZ
Patent application number | Description | Published |
---|---|---|
20100051887 | WIRE STRAINER - A wire strainer has a ratcheted spool rotatably attached to a frame to rotate in a desired direction when tensioning and able to freewheel otherwise. At least one oval/elliptical hole in the shaft accommodates one, two or more wires therein in a particular orientation on the shaft. The oval/elliptical hole is adapted to be dimensioned and positioned on the shaft such that the integrity and strength of the shaft is not compromised or lessened. A projection and a two plane guide means can be situated on the spool whereby the projection is positioned and engages with a portion of a wire and the two plane guide is positioned and assists in deflecting the length of wire not engaged with the projection away from the projection as the spool is rotated during the straining of a wire. Y-shaped reinforcing ribs on the frame provide strengthening and rigidity while tensioning. | 03-04-2010 |
Nicholas H. Wooster, Hutchinson, MN US
Patent application number | Description | Published |
---|---|---|
20140378774 | SURGICAL RETRACTOR FRAME SYSTEM - The present invention generally provides a surgical clamp for use with a surgical retractor support frame. The surgical clamp has a handle that rotates about a first pivot point from a first position to a second position, and a second pivot point eccentric to the first pivot point. The surgical clamp also has an intermediate link with a first portion that rotates about the second pivot point and a second portion that is rotatably connected to a third pivot point on an output link. The intermediate link is manipulated by rotation of the handle, and the intermediate link further manipulates the output link from a first position to a second position. The output link is operably connected to at least one of the first and second clamps to apply a clamping force on a surgical instrument to lock the surgical instrument in place. | 12-25-2014 |
Richard Wooster, Natick, MA US
Patent application number | Description | Published |
---|---|---|
20140187501 | Targeted Conjugates Encapsulated in Particles and Formulations Thereof - Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety via a linker have been designed which can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer or infectious diseases. | 07-03-2014 |
Richard Wooster, Hinxton GB
Patent application number | Description | Published |
---|---|---|
20080206248 | Mutations in ErbB2 associated with cancerous phenotypes - The invention relates to mutations in ErbB2 gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, selection of appropriate anti-cancer therapy and the development of anti-cancer therapeutics. | 08-28-2008 |
20110189688 | GENES - The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics. | 08-04-2011 |
Richard Francis Wooster, Collegeville, PA US
Patent application number | Description | Published |
---|---|---|
20150051215 | PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES - The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). | 02-19-2015 |
Roland P. Wooster, Folsom, CA US
Patent application number | Description | Published |
---|---|---|
20140087705 | TRANSFER OF COMMUNICATION FROM ONE DEVICE TO ANOTHER - Embodiments of apparatus, computer-implemented methods, systems, and computer-readable media are described herein for wirelessly transferring communication roles between devices, using technology such as near field communications (“NFC”), optical communication (e.g., barcodes), BlueTooth and so forth. In various embodiments, a first device may transfer, from the first device to a second device using near field communication, data used by the first device to communicate with a third device, to cause the second device to initiate communication with the third device based on the data. Likewise, in various embodiments, a first device may receive, from a second device using NFC, data used by the second device to communicate with a third device, and to initiate communication with the third device based on the received data. | 03-27-2014 |
Timothy James Wooster, Victoria AU
Patent application number | Description | Published |
---|---|---|
20100305218 | NANOEMULSIONS - The present invention relates to oil-in-water nanoemulsions, processes for their preparation and their use as delivery vehicles for active components for use in opthalmological, dermatological, food, cosmetic, pharmaceutical, agrichemical, textile, polymer and chemical applications. The oil-in-water nanoemulsion comprises up to 40 volume % of an oil phase comprising at least 50 volume % of a triglyceride having a fatty acid chain length of 12 carbon atoms or greater and a hydrophilic non-ionic surfactant having a hydrophilic-lipophilic balance (HLB) greater than 7; and an aqueous phase, in which the oil droplets have an intensity average size of less than 100 nm and the ratio of surfactant to oil is less than 1:1, more preferably 0.2 to 0.8:1. | 12-02-2010 |